Viral vectors have many medical applications
Gene therapy, Immunotherapy (CarT cells) for cancer treatment, vaccines, etc… To produce higher volumes, challenges throughout the manufacturing process must be solved, in particular quality control and yield.
Bioproduction quality control
The proportion between full and empty viral capsids is a key indicator during development and production of viral vecors. Current immunologic testing are very time consuming, and give highly variable results (upto a factor of five depending on the CRO). Hence vectors are produced « blinfolded ».
Hekat’s solution can measure this ratio within minutes.